The thing that stuck with me most about central sensitization is how gaslit women get before someone finally names it. You're told your labs are normal, your joints look fine, maybe you should try yoga — and meanwhile your entire skin feels like a bruise. This is real neuroscience, not a personality trait, and you deserve to have it explained properly.
Learn more about Rose →Estrogen receptors are expressed throughout the dorsal horn of the spinal cord, which is the relay station where pain signals are filtered before reaching the brain. When estrogen levels fall, inhibitory signaling in the dorsal horn weakens, meaning more pain input passes through with less resistance. This is a foundational reason why the same stimulus — a firm handshake, a waistband, a blood pressure cuff — can register as genuinely painful in perimenopause when it never did before.
The brain has a built-in pain-suppression system called the descending inhibitory pathway, which sends signals down from the brainstem to dampen incoming pain messages. Estrogen and progesterone both support the neurotransmitters — particularly serotonin and norepinephrine — that keep this system running efficiently. As hormone levels decline, this top-down brake on pain becomes less effective, leaving the nervous system in a state of amplified vigilance that researchers associate directly with central sensitization.
N-methyl-D-aspartate (NMDA) receptors in the central nervous system play a key role in wind-up, the process by which repeated pain signals progressively amplify rather than stay constant. Estrogen normally acts as a partial brake on NMDA receptor excitability; without adequate estrogen, these receptors become more reactive and harder to settle. This is one reason why pain in perimenopause can feel disproportionate to the trigger and why it lingers long after the stimulus is gone.
Estrogen has well-documented anti-inflammatory effects in the brain and nervous system, partly by regulating microglial cells — the immune cells of the central nervous system. When estrogen drops, microglia become more activated and release pro-inflammatory cytokines that lower the pain threshold and sensitize central pain circuits. This neuroinflammatory shift is now considered one of the primary biological bridges between menopause and conditions like fibromyalgia, which frequently emerges or worsens during perimenopause.
Poor sleep — itself a hallmark symptom of perimenopause — independently lowers pain thresholds by reducing the brain's ability to suppress pain signals during restorative sleep stages. Estrogen loss causes sleep fragmentation, and that fragmentation then deepens central sensitization, which in turn makes sleep harder because pain keeps interrupting it. Research consistently shows that even one or two nights of disrupted sleep measurably increases pain sensitivity in healthy adults, so the cumulative effect of months of broken sleep in perimenopause is significant.
Estrogen modulates the hypothalamic-pituitary-adrenal (HPA) axis, which governs the body's stress response and cortisol output. As estrogen declines, the HPA axis becomes less well-regulated and more prone to hyperreactivity, flooding the system with cortisol in response to ordinary stressors. Chronically elevated cortisol promotes central sensitization by increasing excitatory neurotransmitter activity and reducing the pain-dampening effects of endogenous opioids — the body's own natural painkillers.
The body produces its own opioid-like molecules — including beta-endorphins and enkephalins — that act as natural pain relievers and mood stabilizers. Estrogen is a known upregulator of this endogenous opioid system, and studies show that beta-endorphin levels fall measurably as estrogen declines during menopause. Lower endogenous opioid tone means less natural analgesia, a lower pain threshold, and a reduced capacity to buffer the emotional distress that pain causes — which itself feeds back into pain perception.
Peripheral pain from aching joints, muscles, and connective tissue — all of which lose estrogen-dependent support during menopause — sends a continuous stream of nociceptive (pain) signals into the central nervous system. When the central nervous system receives sustained peripheral input over weeks and months, it undergoes neuroplastic changes that lower its activation threshold and make it easier to trigger pain responses even when the peripheral source quiets down. This is the process by which what starts as joint pain or muscle aching can evolve into a diffuse, hard-to-localize whole-body sensitivity.
When central sensitization is fully established, two specific pain phenomena emerge: allodynia, where stimuli that should not cause pain at all — light touch, fabric, temperature changes — become genuinely painful, and hyperalgesia, where normally painful stimuli hurt far more than they should. Both are well-documented in postmenopausal women and in conditions like vulvodynia and interstitial cystitis that surge in prevalence around menopause. Recognizing these as neurological phenomena rather than tissue damage or emotional overreaction is essential for finding treatments that actually target the right mechanism.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.